141 related articles for article (PubMed ID: 12558977)
1. Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra.
Cobb WS; Abercrombie ED
J Neurochem; 2003 Feb; 84(3):576-84. PubMed ID: 12558977
[TBL] [Abstract][Full Text] [Related]
2. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
Heeringa MJ; Abercrombie ED
J Neurochem; 1995 Jul; 65(1):192-200. PubMed ID: 7790860
[TBL] [Abstract][Full Text] [Related]
3. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
Cobb WS; Abercrombie ED
Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
[TBL] [Abstract][Full Text] [Related]
4. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
Abercrombie ED; DeBoer P
J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of L-DOPA to dopamine in the substantia nigra of freely moving rats: effect of dopamine receptor agonists and antagonists.
Sarre S; Vandeneede D; Ebinger G; Michotte Y
J Neurochem; 1998 Apr; 70(4):1730-9. PubMed ID: 9523592
[TBL] [Abstract][Full Text] [Related]
6. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.
Baruch P; Artaud F; Godeheu G; Barbeito L; Glowinski J; Chéramy A
Neuroscience; 1988 Jun; 25(3):889-98. PubMed ID: 2457187
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
[TBL] [Abstract][Full Text] [Related]
8. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
Santiago M; Westerink BH
Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol.
Cobb WS; Abercrombie ED
J Neurosci; 2002 Feb; 22(4):1407-13. PubMed ID: 11850467
[TBL] [Abstract][Full Text] [Related]
10. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin.
Hery F; Soubrie P; Bourgoin S; Motastruc JL; Artaud F; Glowinski J
Brain Res; 1980 Jul; 193(1):143-51. PubMed ID: 6247027
[TBL] [Abstract][Full Text] [Related]
11. Evidence for different exocytosis pathways in dendritic and terminal dopamine release in vivo.
Bergquist F; Niazi HS; Nissbrandt H
Brain Res; 2002 Sep; 950(1-2):245-53. PubMed ID: 12231250
[TBL] [Abstract][Full Text] [Related]
12. Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra.
Burke MV; Nocjar C; Sonneborn AJ; McCreary AC; Pehek EA
J Neurochem; 2014 Nov; 131(4):432-43. PubMed ID: 25073477
[TBL] [Abstract][Full Text] [Related]
13. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
Yamamoto BK; Nash JF; Gudelsky GA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
[TBL] [Abstract][Full Text] [Related]
14. Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission.
Andersson DR; Nissbrandt H; Bergquist F
Eur J Neurosci; 2006 Jul; 24(2):617-24. PubMed ID: 16903863
[TBL] [Abstract][Full Text] [Related]
15. The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat.
Westerink BH; Santiago M; De Vries JB
Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):523-9. PubMed ID: 1528270
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors.
Marti M; Mela F; Bianchi C; Beani L; Morari M
J Neurochem; 2002 Nov; 83(3):635-44. PubMed ID: 12390525
[TBL] [Abstract][Full Text] [Related]
17. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
[TBL] [Abstract][Full Text] [Related]
18. Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod.
Bergquist F; Shahabi HN; Nissbrandt H
Brain Res; 2003 May; 973(1):81-91. PubMed ID: 12729956
[TBL] [Abstract][Full Text] [Related]
19. Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
Andersson DR; Björnsson E; Bergquist F; Nissbrandt H
Exp Neurol; 2010 Jan; 221(1):251-9. PubMed ID: 19944096
[TBL] [Abstract][Full Text] [Related]
20. 5-HT4 receptor involvement in the serotonin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: a microdialysis study.
Thorré K; Ebinger G; Michotte Y
Brain Res; 1998 Jun; 796(1-2):117-24. PubMed ID: 9689461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
